Related Experiment Video
Updated: Feb 27, 2026

Use of a Piglet Model for the Study of Anesthetic-induced Developmental Neurotoxicity AIDN: A Translational Neuroscience Approach
Published on: June 11, 2017
Overexpression cdc42 attenuates isoflurane-induced neurotoxicity in developmental brain of rats
Xi Fang1, Shiyong Li1, Qiang Han1
1Department of Anesthesiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan 430030, Hubei, China.
Insights
Isoflurane anesthesia harms young rat brains, causing neurotoxicity and cognitive deficits by suppressing the CaMKIIα/cdc42/PAK3 pathway. Overexpressing cdc42 protected against these isoflurane-induced effects.
Area of Science:
- Neuroscience
- Anesthesiology
- Developmental Biology
Background:
- General anesthetics like isoflurane are widely used in pediatric surgeries.
- Isoflurane exposure in young animals is linked to neurotoxicity and impaired neurobehavior.
- The precise mechanisms underlying isoflurane-induced neurotoxicity remain unclear.
Purpose of the Study:
- To investigate the impact of isoflurane on the CaMKIIα/cdc42/PAK3 signaling pathway.
- To determine if this pathway is involved in isoflurane-induced neurotoxicity and cognitive deficits.
- To explore the potential protective role of cdc42 against isoflurane's adverse effects.
Main Methods:
- Utilized young rats as a model system.
- Administered isoflurane to assess its effects on specific molecular pathways.
- Manipulated cdc42 expression to evaluate its role in mitigating isoflurane-induced damage.
Main Results:
- Isoflurane exposure suppressed the CaMKIIα/cdc42/PAK3 signaling pathway in young rats.
- This suppression correlated with observed neurotoxicity and cognitive impairment.
- Overexpression of cdc42 reversed the neurotoxic effects and improved cognitive function.
Conclusions:
- The CaMKIIα/cdc42/PAK3 pathway is implicated in isoflurane-induced neurotoxicity and cognitive impairment.
- Cdc42 plays a protective role against isoflurane's detrimental effects on the developing brain.
- Targeting the CaMKIIα/cdc42/PAK3 pathway may offer therapeutic strategies to prevent anesthetic-induced neurotoxicity.
Abstract:
Nowadays many children receive operations with general anesthesia. Isoflurane is a commonly-used general anesthetic. Numbers of studies demonstrated that isoflurane induced neurotoxicity and neurobehavioral deficiency in young rats, however, the underlying mechanism remained unknown. Cell division cycle 42 (cdc42) played an important role in regulating synaptic vesicle trafficking and actin dynamics in neuron, which closely linked to synaptic plasticity and dendritic spine formation. Meanwhile, cdc42 also involved in many neurodegenerative diseases. However, whether cdc42 provided a protective role in isoflurane induced synaptogenesis dysfunction still unknown. As the upstream of cdc42, calcium/Calmodulin-dependent protein kinase II (CaMKII) interacts with ion channels such as VDCCs and N-methyl-d-aspartate receptors (NMDARs), which closely associated with neuroapoptosis and cognitive deficiency in developing brain. The phosphorylation of CaMKIIα at Thr 286 plays an important role in introduction and maintenance of long-term potentiation (LTP). Therefore, we investigated the effect of isoflurane on cdc42 and its upstream Calcium/Calmodulin-dependent protein kinase II (CaMKII) and its downstream p21 activated kinase 3 (PAK3), then determined whether CaMKIIα/cdc42/PAK3 signaling pathway was involved in neurotoxicity and cognitive deficiency induced by isoflurane. Our study found that isoflurane induced neurotoxicity and resulted in cognitive impairment in young rats through suppressed CaMKIIα/cdc42/PAK3 signaling pathway. Cdc42 over-expression could reverse neurotoxicity and improve cognitive impairment induced by isoflurane.
More Related Videos
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
09:49Assessing Changes in Synaptic Plasticity Using an Awake Closed-Head Injury Model of Mild Traumatic Brain Injury
Published on: January 20, 2023